Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


1 Acta Psychiatr Scand
1 Biol Psychiatry
1 Br J Psychiatry
3 Mol Psychiatry
1 Neuropsychopharmacology
1 PLoS One
4 Psychiatry Res
1 Psychol Med
8 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Psychiatr Scand

  1. TANSKANEN A, Tiihonen J, Taipale H
    Mortality in schizophrenia: 30-year nationwide follow-up study.
    Acta Psychiatr Scand. 2018 Jun 13. doi: 10.1111/acps.12913.
    PubMed     Text format     Abstract available

    Biol Psychiatry

  2. MANTYLA T, Nummenmaa L, Rikandi E, Lindgren M, et al
    Aberrant Cortical Integration in First-Episode Psychosis During Natural Audiovisual Processing.
    Biol Psychiatry. 2018 May 3. pii: S0006-3223(18)31469.
    PubMed     Text format     Abstract available

    Br J Psychiatry

  3. MARWICK KFM, Stevenson AJ, Davies C, Lawrie SM, et al
    Application of n-of-1 treatment trials in schizophrenia: systematic review - ERRATUM.
    Br J Psychiatry. 2018 Jun 11:1. doi: 10.1192/bjp.2018.
    PubMed     Text format     Abstract available

    Mol Psychiatry

  4. CHAUMETTE B, Ferrafiat V, Ambalavanan A, Goldenberg A, et al
    Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.
    Mol Psychiatry. 2018 Jun 12. pii: 10.1038/s41380-018-0103.
    PubMed     Text format     Abstract available

  5. SUN D, Ching CRK, Lin A, Forsyth JK, et al
    Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Mol Psychiatry. 2018 Jun 13. pii: 10.1038/s41380-018-0078.
    PubMed     Text format     Abstract available

  6. EGERTON A, Broberg BV, Van Haren N, Merritt K, et al
    Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE).
    Mol Psychiatry. 2018 Jun 7. pii: 10.1038/s41380-018-0082.
    PubMed     Text format     Abstract available


  7. AVRAM M, Brandl F, Bauml J, Sorg C, et al
    Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia.
    Neuropsychopharmacology. 2018 Apr 12. pii: 10.1038/s41386-018-0059.
    PubMed     Text format     Abstract available

    PLoS One

  8. ZHANG T, Li J, Yu H, Shi Y, et al
    Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.
    PLoS One. 2018;13:e0198690.
    PubMed     Text format     Abstract available

    Psychiatry Res

  9. PAWELCZYK A, Lojek E, Zurner N, Gawlowska-Sawosz M, et al
    Higher-order language dysfunctions as a possible neurolinguistic endophenotype for schizophrenia: Evidence from patients and their unaffected first degree relatives.
    Psychiatry Res. 2018;267:63-72.
    PubMed     Text format     Abstract available

  10. VASS E, Fekete Z, Simon V, Simon L, et al
    Interventions for the treatment of theory of mind deficits in schizophrenia: Systematic literature review.
    Psychiatry Res. 2018;267:37-47.
    PubMed     Text format     Abstract available

  11. TAN CS, Lim LW, Ting DS
    Assessment of choroidal and retinal thickness in psychosis.
    Psychiatry Res. 2018 May 30. pii: S0165-1781(18)30704.
    PubMed     Text format    

  12. HARO JM, Altamura C, Corral R, Elkis H, et al
    Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Psychiatry Res. 2018;267:56-62.
    PubMed     Text format     Abstract available

    Psychol Med

  13. LEMMERS-JANSEN ILJ, Fett AJ, Hanssen E, Veltman DJ, et al
    Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Psychol Med. 2018 Jun 13:1-11. doi: 10.1017/S003329171800140.
    PubMed     Text format     Abstract available

    Schizophr Res

  14. NADALIN S, Rebic J, Ruzic K, Buretic-Tomljanovic A, et al
    The relationship between components of metabolic syndrome and disease onset in patients with schizophrenia.
    Schizophr Res. 2018 Jun 4. pii: S0920-9964(18)30298.
    PubMed     Text format    

  15. BIJJAL S, Ganesh S, Rawat VS, Agarwal V, et al
    Six months' course and outcome of metabolic abnormalities in a cohort of patients with schizophrenia in rural India.
    Schizophr Res. 2018 Jun 4. pii: S0920-9964(18)30273.
    PubMed     Text format    

  16. PERALTA V, Cuesta MJ
    Modeling neuromotor pathology in schizophrenia: A window to brain mechanisms and clinical insight into the syndrome.
    Schizophr Res. 2018 Jun 5. pii: S0920-9964(18)30305.
    PubMed     Text format    

  17. TOUSKOVA TP, Bob P, Pec O, Mishara A, et al
    Insight and cortisol responses in women with first episode psychosis.
    Schizophr Res. 2018 Jun 6. pii: S0920-9964(18)30313.
    PubMed     Text format    

  18. TAYLOR MJ, Yim S
    Is there rebound psychosis on withdrawal of antipsychotic medication in schizophrenia?
    Schizophr Res. 2018 Jun 8. pii: S0920-9964(18)30341.
    PubMed     Text format    

  19. LEE SW, Lee A, Choi TK, Kim B, et al
    White matter abnormalities of the tapetum and their associations with duration of untreated psychosis and symptom severity in first-episode psychosis.
    Schizophr Res. 2018 Jun 9. pii: S0920-9964(18)30315.
    PubMed     Text format    

  20. ROCCA P, Galderisi S, Rossi A, Bertolino A, et al
    Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.
    Schizophr Res. 2018 Jun 10. pii: S0920-9964(18)30314.
    PubMed     Text format     Abstract available

  21. HARDY M, Jackson C, Byrne J
    Antipsychotic adherence and emergency department utilization among patients with schizophrenia.
    Schizophr Res. 2018 Jun 10. pii: S0920-9964(18)30339.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.